Warberg Asset Management »

Briacell Therapeutics Corp shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Briacell Therapeutics Corp shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $119k 115k 1.03

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Put Put Option
Lumentum Hldgs Note 0.500%12/1 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Microchip Technology Note 1.625% 2/1 (Principal)
Invesco Qqq Tr Put Put Option
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Wisdomtree Note 3.250% 6/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Lci Inds Note 3.000% 3/0 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Cornerstone Strategic Value (CLM)
Txnm Energy Note 5.750% 6/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Briacell Therapeutics Corp

Citadel Advisors
Armistice Capital
Cable Car Capital
Empery Asset Management
Hudson Bay Capital Management
Warberg Asset Management
Clear Street Group
Iridian Asset Management
Boothbay Fund Management
FNY Investment Advisers

View all funds holding Briacell Therapeutics Corp